Inhibition of Epstein-Barr Virus Replication by a Benzimidazole l-Riboside: Novel Antiviral Mechanism of 5,6-Dichloro-2-(Isopropylamino)-1-β-l-Ribofuranosyl-1H-Benzimidazole

Although a number of antiviral drugs inhibit replication of Epstein-Barr virus (EBV) in cell culture, and acyclovir (ACV) suppresses replication in vivo, currently available drugs have not proven effective for treatment of EBV-associated diseases other than oral hairy leukoplakia. Benzimidazole ribo...

ver descrição completa

Detalhes bibliográficos

Publicado no:	J Virol
Principais autores:	Zacny, Valerie L., Gershburg, Eduard, Davis, Michelle G., Biron, Karen K., Pagano, Joseph S.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1999
Assuntos:	Vaccines and Antiviral Agents
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC104252/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/10438815/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.73.9.7271-7277.1999
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!